Bioethics Observatory Gene therapy clinical applications are surely the most complex drugs in history. After a traditional trial-and-error phase is now achieving successful applications

Bioethics Observatory Gene therapy clinical applications are surely the most complex drugs in history. After a traditional trial-and-error phase is now achieving successful applications

Bioethics Observatory Healthcare professionals freedom of conscience questioned in Europe

Bioethics Observatory Terminal cancer healed by a new revolutionary therapy in a patient unresponsive to already known treatment

SPECIAL REPORTS

Gene therapy recent clinical applications As we said in a previous article gene therapy is facing a new promising stage (see WHY). On 9 January this year, a review was published in JAMA on the latest advances in gene therapy, making reference to specific advances in humans. The first refers to gene therapy treatment of a 7-year-old boy with a serious life-threatening skin disease, epidermolysis … Read more.

Human embryos research and the Politics of Bioethics Ethical objective questions posed by human embryo experimentation are exacerbated by the deregulate gene editing techniques research including biohackers A book has been published by Columbia University, entitled “Experiments in Democracy. Human Embryo Research and the Politics of Bioethics”. Given his interest, we considered it relevant to discuss … Read more.

NEWS

Monitoring must continues on gene therapy possible risks In order to introduce DNA into cells, gene therapy  uses viruses, but now experimental studies in animals have suggested that when high doses of viruses are used, the process is not as safe as believed… Read more.

A new step in contraception without pills. The projected contraceptive vaccine A contraceptive vaccine which mechanism of action destroys a human life that has already begun its journey is being developed… Read more.

Human-sheep hybrids created for the first time to develop organs Created for the first time by scientists at Stanford University. The scientists grew the embryos in a surrogate sheep, allowing them to gestate up to 3 weeks. These experiments pave the way for the creation of farms of quasi-human hybrid animals, which can be used … Read more.

Belgium considers euthanizing psychiatric patients without meeting legal requirements The practice is theoretical determined by law and require some specific conditions, such as imminent death, constant and unbearable pain, and the patient’s request for euthanasia. In an earlier article, we refer to the debate of euthanasia… Read more.

Doctor's dilemma where the Euthanasia Law has been approved A recent interview published by New England Journal Medicine gives an overview of the doctors' dilemmas giving an update on the euthanasia practice in… Read more.

IN BRIEF

Artificial organoids generated from cancer cells These creation of organoids similar to others in our body have objective biomedical applications. In this case is for cancer experimentation… Read more.

To what extent should the opinion of children treated medically be taken into account? In a series of articles published in the American Journal of Bioethics, it is suggested that having children participate in the medical procedures that they have to undergo continues… Read more.

Is the right of conscientious objection protected in Europe when it comes to abortion? The possibility of invoking conscientious objection for those healthcare providers who are against participating in this practice is not yet well defined. This topic has been widely addressed theoretically, but there are objective shortcomings in its practical application… Read more.

Cancer cell therapy, still experimental, beats terminal breast cancer woman with secondary cancers She had tennis ball-sized tumours in her liver and secondary cancers throughout her body. She told the BBC: "About a … Read more.

First gene therapy drug approved in the U.S. It is for a serious genetic disease that causes vision loss and even blindness. The drug used is called LEXTURNA… Read more.